Remission of proteinuria under therapeutic intervention and the renal outcomes in Japanese patients with lupus nephritis class III and IV

References

• Maroz N, Segal MS. Lupus nephritis and end-stage kidney disease. Am J Med Sci. 2013;346(4):319–23.
   PubMed Web of Science ®Google Scholar
• Cameron JS. Lupus nephritis. J Am Soc Nephrol. 1999;10(2):413–24.
   PubMed Web of Science ®Google Scholar
• Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, et al. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide. Ann Rheum Dis. 2010;69(01):61–4.
   PubMedGoogle Scholar
• Hanly JG, O’Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford). 2016;55(2):252–62.
   PubMed Web of Science ®Google Scholar
• Jakes RW, Bae SC, Louthrenoo W, Mok C, Navarra S, Kwon N. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res. 2012;64(2):159–68.
   PubMed Web of Science ®Google Scholar
• Resende A, Titan S, Barros R, Woronik V. Worse renal outcome of lupus nephritis in male patients: a case-control study. Lupus 2011;20(6):561–7.
   PubMed Web of Science ®Google Scholar
• Faurschou M, Starklint H, Halberg P, Jacobsen S. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. J Rheumatol 2006;33:1563–9.
   PubMed Web of Science ®Google Scholar
• Parikh SV, Nagaraja HN, Hebert L, Rovin B. Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis. Clin J Am Soc Nephrol. 2014;9(2):279–84.
   PubMed Web of Science ®Google Scholar
• Ikeuchi H, Hiromura K, Kayakabe K, Tshilela KA, Uchiyama K, Hamatani H, et al. Renal outcomes in mixed proliferative and membranous lupus nephritis (Class III/IV + V): a long-term observational study. Mod Rheumatol. 2016;26(6):908–13.
   PubMed Web of Science ®Google Scholar
• Chen YE, Korbet SM, Katz RS, Schwartz MM, Lewis EJ. Value of a complete or partial remission in severe lupus nephritis. Clin J Am Soc Nephrol. 2008;3(1):46–53.
   PubMed Web of Science ®Google Scholar
• Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD. Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis. 2000;35(5):904–14.
   PubMed Web of Science ®Google Scholar
• Illei GG, Takada K, Parkin D, Austin HA, Crane M, Yarboro CH, et al. Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies. Arthritis Rheum. 2002;46(4):995–1002.
   PubMed Web of Science ®Google Scholar
• Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, et al. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum. 2004;50(12):3934–40.
   PubMed Web of Science ®Google Scholar
• Tamirou F, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Fiehn C, et al. Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis. Ann Rheum Dis. 2016;75(3):526–31.
   PubMed Web of Science ®Google Scholar
• Donadio JV, Bergstralh EJ, Grande JP, Rademcher D. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant. 2002;17(7):1197–203.
   PubMed Web of Science ®Google Scholar
• Hirano K, Kawamura T, Tsuboi N, Okonogi H, Miyazaki Y, Ikeda M, et al. The predictive value of attenuated proteinuria at 1 year after steroid therapy for renal survival in patients with IgA nephropathy. Clin Exp Nephrol. 2013;17(4):555–62.
   PubMed Web of Science ®Google Scholar
• Okabayashi Y, Tsuboi N, Haruhara K, Kanzaki G, Koike K, Shimizu A, et al. Reduction of proteinuria by therapeutic intervention improves the renal outcome of elderly patients with IgA nephropathy. Clin Exp Nephrol. 2016;20(6):910–7.
   PubMed Web of Science ®Google Scholar
• Shiiki H, Saito T, Nishitani Y, Mitarai T, Yorioka N, Yoshimura A, et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int. 2004;65(4):1400–7.
   PubMed Web of Science ®Google Scholar
• Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15(2):241–50.
   PubMed Web of Science ®Google Scholar
• Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–92.
   PubMed Web of Science ®Google Scholar
• Chotayaporn T, Kasitanon N, Sukitawut W, Louthrenoo W. Comparison of proteinuria determination by urine dipstick, spot urine protein creatinine index, and urine protein 24 hours in lupus patients. J Clin Rheumatology. 2011;17(3):124.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288–91.
   PubMed Web of Science ®Google Scholar
• Barbour SJ, Cattran DC, Espino-Hernandez G, Hladunewich MA, Reich HN. Identifying the ideal metric of proteinuria as a predictor of renal outcome in idiopathic glomerulonephritis. Kidney Int. 2015;88(6):1392–401.
   PubMed Web of Science ®Google Scholar
• Austin HA, Muenz LR, Joyce KM, Antonovych TT, Balow JE. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int. 1984;25(4):689–95.
   PubMed Web of Science ®Google Scholar
• Korbet SM, Lewis EJ. Severe lupus nephritis: the predictive value of a ≥50% reduction in proteinuria at 6 months. Nephrol Dial Transplant. 2013;28(9):2313–8.
   PubMed Web of Science ®Google Scholar
• Koo H, Kim S, Chin H. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis. Lupus 2016;25(1):3–11.
   PubMed Web of Science ®Google Scholar
• So MW, Koo BS, Kim Y-GG, Lee C-KK, Yoo B. Predictive value of remission status after 6 months induction therapy in patients with proliferative lupus nephritis: a retrospective analysis. Clin Rheumatol. 2011;30(11):1399–405.
   PubMed Web of Science ®Google Scholar
• Ugolini-Lopes M, Seguro L, Castro M, Daffre D, Lopes A, Borba E, et al. Early proteinuria response: a valid real-life situation predictor of long-term lupus renal outcome in an ethnically diverse group with severe biopsy-proven nephritis? Lupus Sci Med. 2017;4(1):e000213.
   PubMed Web of Science ®Google Scholar
• Dall'Era M, Cisternas MG, Smilek DE, Straub L, Houssiau FA, Cervera R, et al. Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort. Arthritis Rheumatol. 2015;67:1305–13.
   PubMed Web of Science ®Google Scholar